Project Details
| Short title | BUS-P3-02 |
|---|---|
| Acronym | CALM-2 |
| Status | Active |
| Effective start/end date | 26/08/24 → 15/05/29 |
CTU: A Phase 3, 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study with Open-label Extension of BLU-5937 in Adult Participants with Refractory Chronic Cough Including Unexplained Chronic Cough (CALM-2).
- Ing, Alvin (Primary Chief Investigator)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
Project: Research